Skip to content
media1

Group News

Aspen increases revenue by 9% to R38,6 billion

Sep 9, 2020

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced reviewed provisional Group financial results for the year ended 30 June 2020. COMMENTARY RESHAPING OF THE GROUP The recently announced agreement to divest the assets related to the commercialisation of Aspen’s Thrombosis business in Europe to Mylan…

Read More >>

Divestment of Aspen’s European Thrombosis Business to Mylan and withdrawal of cautionary

Sep 8, 2020

Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is pleased to announce that, Aspen Global Incorporated (“AGI”), its wholly owned subsidiary incorporated in Mauritius, has concluded an agreement in terms of which Mylan Ireland Limited (“Mylan”) will acquire the commercialisation rights and related intellectual property relating to Aspen’s Thrombosis…

Read More >>

Aspen scoops prized Adam Smith Treasury Award

Jul 22, 2020

Aspen’s Group Treasury Team was recently recognised when they were awarded the highly acclaimed Adam Smith 2020 Best In Class Treasury Solution In Africa Award.

Read More >>

Aspen celebrates a decade of participation in Mandela Day

Jul 17, 2020

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is celebrating its 10th year of participation in the annual Mandela International Day (Mandela Day) campaign. Stephen Saad, Aspen Group Chief Executive said, “We participated in our first initiative in 2011 when we partnered with the Rekopane Inclusive Development…

Read More >>

Aspen debuts in the FTSE4Good Index Series

Jul 9, 2020

The annual FTSE Russell Environmental, Social and Governance (ESG) Ratings have been published and Aspen has been included as a constituent member in the global FTSE4Good Index Series for the first time. Jeanette Englund Aspen Group Risk Sustainability Manager said, “We are delighted to be included in the global FTSE4Good Index Series for the first…

Read More >>

Aspen donates electronic devices valued at R2.4 million to assist UP medical students

May 6, 2020

An Aspen Pharmacare initiative Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company headquartered in South Africa, has donated 600 internet-enabled electronic devices valued at R2.4 million to support students from the Faculty of Health Sciences at the University of Pretoria (UP). Stavros Nicolaou, Aspen Pharmacare Senior Executive: Strategic Trade said, “Aspen…

Read More >>

AGI: Covid-19 support in Mauritius

May 5, 2020

Aspen donates anaesthetic medicines to patients in critical condition An Aspen Global Incorporated Initiative Ministry of Health, Emmanuel Anquetil Building, Port Louis, 29 April 2020: In a major contribution in our fight against Covid-19, Aspen Global Incorporated, the Mauritian subsidiary of Aspen Pharmacare Holdings (a multinational pharmaceutical company), has donated approximately 30,000 vials of three…

Read More >>

Message to all Aspen employees from Gus Attridge

Apr 6, 2020
Read More >>

Aspen responds to President Cyril Ramaphosa’s call to action on COVID-19

Mar 17, 2020

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced that the Group is actively focused on employees carrying out best practices in respect of the prevention and containment of COVID-19 while ensuring continued supply of medicines to patients. Stephen Saad, Aspen Group Chief Executive said, “As…

Read More >>

Aspen increases revenue and progresses on medium-term priorities

Mar 5, 2020

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 31 December 2019. GROUP PERFORMANCE (CONTINUING OPERATIONS) Aspen increased revenue by 3% to R18,4 billion for the six months ended 31 December 2019. Commercial Pharma increased 2% to…

Read More >>
Scroll To Top